|

CYB003 Clinical Trials

3 actively recruiting trials across 3 locations

Pipeline

Phase 3: 3

Top Sponsors

  • Cybin IRL Limited3

Indications

  • Depression3
  • Major Depressive Disorder2
  • Depression Disorder1
  • Major Depressive Disorder (MDD)1
  • Depression Disorders1

Birmingham, Alabama1 trial

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

UAB Psychiatry and Behavioral Neurology

Phase 3

Phoenix, Arizona1 trial

"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"

Scottsdale Research Institute

Phase 3

San Francisco, California1 trial

Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)

Open Mind Collective / UCSF Medical Center - Mount Zion

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.